HCA Healthcare

Scholarly Commons
Cardiology

Research & Publications

1-23-2020

A Crescent Lesion Set Avoiding Esophageal Contact is not Inferior
to Standard WACA for Paroxysmal Afib: A Pilot Study
Jeraim Craig
David Goldgrab DO
HCA Healthcare, david.goldgrab@hcahealthcare.com

Sokol Kalaveshi
HCA Healthcare, Sokol.Kalaveshi@hcaheatlhcare.com

Ruifang Yang MD
HCA Healthcare, ruifang.yang@hcahealthcare.com

Jose Luis Henao
HCA Healthcare, jose.henao@hcahealthcare.com

See next page for additional authors

Follow this and additional works at: https://scholarlycommons.hcahealthcare.com/cardiology
Part of the Cardiology Commons

Recommended Citation
Craig J, Goldgrab D, Kalaveshi S, et al. AFS-34 A Crescent Lesion set avoiding esophageal contact is not
inferior to standard WACA for paroxysmal afib: A Pilot Study. Poster presented at 25th Annual
International Atrial Fibrillation Symposium; January 23-25, 2020; Washington D.C.

This Poster is brought to you for free and open access by the Research & Publications at Scholarly Commons. It
has been accepted for inclusion in Cardiology by an authorized administrator of Scholarly Commons.

Authors
Jeraim Craig, David Goldgrab DO, Sokol Kalaveshi, Ruifang Yang MD, Jose Luis Henao, Stephen Mester
MD, and Christian Perzanowski MD

This poster is available at Scholarly Commons: https://scholarlycommons.hcahealthcare.com/cardiology/19

A Crescent Lesion Set Avoiding Esophageal Contact is Not Inferior to
Standard WACA For Paroxysmal A-fib: A Pilot Study
David Goldgrab DO, Sokol Kalaveshi MD, Ruifang Yang, MD, PHD, Jose L Henao MD, Stephen Mester, MD, FACC, Christian Perzanowski MD, FACC, FHRS, FAHA

Background
•

•

•

•

Results
•

Radiofrequency ablation using wide area
circumferential ablation (WACA) is the standard
approach for paroxysmal atrial fibrillation (pAF).

A total of 33 patients were followed, 19 WACA, 14
CL. All PVs were isolated as determined by entrance
and exit block.

•

Invariably the posterior wall requires RFA to isolate
the pulmonary veins (PV). However, excessive
heating of the posterior wall can lead to
catastrophic esophageal injury.

There were no differences in the clinical variables
(age, gender, left atrial size and comorbidities)
however follow-up was longer in the WACA group
(210 vs 58 days, p < 0.00025).

•

It has been reported that pulmonary vein isolation
can be achieved without fully encircling the PV
antra.

In addition, the procedure times were less with CL
(135 vs 166 minutes, p < 0.025) as expected.

•

When WACA is not feasible then a
semilunar/crescent lesion set (CL) limiting posterior
wall ablation can be considered.

Overall, both groups exhibited a low AF burden (1 or
less clinical episode captured on follow up) [WACA
74% (95% CI 54, 94 )]; [CL 79% (95% CI 57, 100)].

•

There was no statistical difference in the number of
patients maintaining a low AF burden as depicted with
the Kaplan-Meier curves (log rank test, p = 0.134).
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PA view of electroanatomic map of left atrium exhibiting crescent
lesion, note no RF done on posterior limb of right WACA

Methods
•

A non-randomized prospective study comparing
highly symptomatic patients with pAF who
underwent WACA with a study group who had a CL
applied to the posterior wall.

•

A multielectrode (pentarray) and irrigated tip
ablation (Thermacool SF, Biosenese Webster,
USA) catheters were used for all cases.

•

Red arrows denote esophageal course, posterior to right PV

The criteria for employing a CL was heating > 0.5C
as recorded by luminal esophageal temperature
probe or identifying a visually thin posterior wall.

•

Both cohorts were followed longitudinally with
frequent ambulatory monitoring and clinical
evaluations.

•

The survival endpoint was a low/mild AF burden as
defined as one or less episodes at any time during
follow-up.

Conclusion
•

CL strategy does not appear to be inferior to
standard WACA technique when avoiding the
esophagus is a concern. Larger studies and longer
follow-up data are needed to validate these
findings.
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